238 related articles for article (PubMed ID: 26344757)
21. Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes.
Feaster TK; Casciola M; Narkar A; Blinova K
J Vis Exp; 2022 Dec; (190):. PubMed ID: 36591970
[TBL] [Abstract][Full Text] [Related]
22. Quantitatively characterizing drug-induced arrhythmic contractile motions of human stem cell-derived cardiomyocytes.
Hoang P; Huebsch N; Bang SH; Siemons BA; Conklin BR; Healy KE; Ma Z; Jacquir S
Biotechnol Bioeng; 2018 Aug; 115(8):1958-1970. PubMed ID: 29663322
[TBL] [Abstract][Full Text] [Related]
23. Video-based assessment of drug-induced effects on contractile motion properties using human induced pluripotent stem cell-derived cardiomyocytes.
Okai Y; Matsune K; Yamanaka K; Matsui T; Pfeiffer Kaushik E; Harada K; Kohara H; Miyawaki A; Ozaki H; Wagoner M; Shinozawa T
J Pharmacol Toxicol Methods; 2020 Sep; 105():106893. PubMed ID: 32619502
[TBL] [Abstract][Full Text] [Related]
24. Electrical impedance-based contractile stress measurement of human iPSC-Cardiomyocytes.
Wang X; Wang L; Dou W; Huang Z; Zhao Q; Malhi M; Maynes JT; Sun Y
Biosens Bioelectron; 2020 Oct; 166():112399. PubMed ID: 32692665
[TBL] [Abstract][Full Text] [Related]
25. Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro.
Kensah G; Roa Lara A; Dahlmann J; Zweigerdt R; Schwanke K; Hegermann J; Skvorc D; Gawol A; Azizian A; Wagner S; Maier LS; Krause A; Dräger G; Ochs M; Haverich A; Gruh I; Martin U
Eur Heart J; 2013 Apr; 34(15):1134-46. PubMed ID: 23103664
[TBL] [Abstract][Full Text] [Related]
26. MUSCLEMOTION: A Versatile Open Software Tool to Quantify Cardiomyocyte and Cardiac Muscle Contraction In Vitro and In Vivo.
Sala L; van Meer BJ; Tertoolen LGJ; Bakkers J; Bellin M; Davis RP; Denning C; Dieben MAE; Eschenhagen T; Giacomelli E; Grandela C; Hansen A; Holman ER; Jongbloed MRM; Kamel SM; Koopman CD; Lachaud Q; Mannhardt I; Mol MPH; Mosqueira D; Orlova VV; Passier R; Ribeiro MC; Saleem U; Smith GL; Burton FL; Mummery CL
Circ Res; 2018 Feb; 122(3):e5-e16. PubMed ID: 29282212
[TBL] [Abstract][Full Text] [Related]
27. Impact of Ionizing Radiation on Electrophysiological Behavior of Human-induced Ipsc-derived Cardiomyocytes on Multielectrode Arrays.
Becker BV; Seeger T; Beiert T; Antwerpen M; Palnek A; Port M; Ullmann R
Health Phys; 2018 Jul; 115(1):21-28. PubMed ID: 29787427
[TBL] [Abstract][Full Text] [Related]
28. In Situ Expansion, Differentiation, and Electromechanical Coupling of Human Cardiac Muscle in a 3D Bioprinted, Chambered Organoid.
Kupfer ME; Lin WH; Ravikumar V; Qiu K; Wang L; Gao L; Bhuiyan DB; Lenz M; Ai J; Mahutga RR; Townsend D; Zhang J; McAlpine MC; Tolkacheva EG; Ogle BM
Circ Res; 2020 Jul; 127(2):207-224. PubMed ID: 32228120
[TBL] [Abstract][Full Text] [Related]
29. Same-Single-Cell Analysis of Pacemaker-Specific Markers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Subtypes Classified by Electrophysiology.
Yechikov S; Copaciu R; Gluck JM; Deng W; Chiamvimonvat N; Chan JW; Lieu DK
Stem Cells; 2016 Nov; 34(11):2670-2680. PubMed ID: 27434649
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of mTOR Signaling Enhances Maturation of Cardiomyocytes Derived From Human-Induced Pluripotent Stem Cells via p53-Induced Quiescence.
Garbern JC; Helman A; Sereda R; Sarikhani M; Ahmed A; Escalante GO; Ogurlu R; Kim SL; Zimmerman JF; Cho A; MacQueen L; Bezzerides VJ; Parker KK; Melton DA; Lee RT
Circulation; 2020 Jan; 141(4):285-300. PubMed ID: 31707831
[TBL] [Abstract][Full Text] [Related]
31. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
[TBL] [Abstract][Full Text] [Related]
32. Influence of field potential duration on spontaneous beating rate of human induced pluripotent stem cell-derived cardiomyocytes: Implications for data analysis and test system selection.
Rast G; Kraushaar U; Buckenmaier S; Ittrich C; Guth BD
J Pharmacol Toxicol Methods; 2016; 82():74-82. PubMed ID: 27521052
[TBL] [Abstract][Full Text] [Related]
33. Aligned human induced pluripotent stem cell-derived cardiac tissue improves contractile properties through promoting unidirectional and synchronous cardiomyocyte contraction.
Takada T; Sasaki D; Matsuura K; Miura K; Sakamoto S; Goto H; Ohya T; Iida T; Homma J; Shimizu T; Hagiwara N
Biomaterials; 2022 Feb; 281():121351. PubMed ID: 34979417
[TBL] [Abstract][Full Text] [Related]
34. Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair.
Tiburcy M; Hudson JE; Balfanz P; Schlick S; Meyer T; Chang Liao ML; Levent E; Raad F; Zeidler S; Wingender E; Riegler J; Wang M; Gold JD; Kehat I; Wettwer E; Ravens U; Dierickx P; van Laake LW; Goumans MJ; Khadjeh S; Toischer K; Hasenfuss G; Couture LA; Unger A; Linke WA; Araki T; Neel B; Keller G; Gepstein L; Wu JC; Zimmermann WH
Circulation; 2017 May; 135(19):1832-1847. PubMed ID: 28167635
[TBL] [Abstract][Full Text] [Related]
35. Methods for in vitro functional analysis of iPSC derived cardiomyocytes - Special focus on analyzing the mechanical beating behavior.
Laurila E; Ahola A; Hyttinen J; Aalto-Setälä K
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1864-72. PubMed ID: 26707468
[TBL] [Abstract][Full Text] [Related]
36. Speckle-Tracking Strain Analysis for Mapping Spatiotemporal Contractility of Induced Pluripotent Stem Cell (iPSC)-Derived Cardiomyocytes.
Izadifar M; Berecz T; Li B; Tang JKKY; Foldes G; Apati A; Nagy A
Curr Protoc; 2023 Sep; 3(9):e889. PubMed ID: 37747346
[TBL] [Abstract][Full Text] [Related]
37. Interferometric Biosensor for High Sensitive Label-Free Recording of HiPS Cardiomyocytes Contraction
Boschi A; Iachetta G; Buonocore S; Hubarevich A; Hurtaud J; Moreddu R; Marta d'Amora ; Formoso MB; Tantussi F; Dipalo M; De Angelis F
Nano Lett; 2024 Jun; 24(22):6451-6458. PubMed ID: 38776267
[TBL] [Abstract][Full Text] [Related]
38. Protocol to measure contraction, calcium, and action potential in human-induced pluripotent stem cell-derived cardiomyocytes.
Zhang JZ; Zhao SR; Tu C; Pang P; Zhang M; Wu JC
STAR Protoc; 2021 Dec; 2(4):100859. PubMed ID: 34746854
[TBL] [Abstract][Full Text] [Related]
39. Effect of Glucose on 3D Cardiac Microtissues Derived from Human Induced Pluripotent Stem Cells.
Balistreri M; Davis JA; Campbell KF; Da Rocha AM; Treadwell MC; Herron TJ
Pediatr Cardiol; 2017 Dec; 38(8):1575-1582. PubMed ID: 28752324
[TBL] [Abstract][Full Text] [Related]
40. Human amniotic mesenchymal stem cell-derived induced pluripotent stem cells may generate a universal source of cardiac cells.
Ge X; Wang IN; Toma I; Sebastiano V; Liu J; Butte MJ; Reijo Pera RA; Yang PC
Stem Cells Dev; 2012 Oct; 21(15):2798-808. PubMed ID: 22530853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
